Logo for Tharimmune Inc

Tharimmune Investor Relations Material

Latest events

Logo for Tharimmune

Q1 2025

11 May, 2025
Logo for Tharimmune

Q4 2024

26 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Tharimmune Inc

Access all reports
Tharimmune Inc. is a biopharmaceutical company focused on the development of immune-modulating therapies for inflammatory diseases and cancer. The company specializes in small molecule and biologic drug candidates designed to regulate immune responses and target disease pathways. Tharimmune conducts clinical research and drug development to address unmet medical needs in autoimmune disorders, oncology, and fibrosis-related conditions. The company is headquartered in Westlake Village, California, and its shares are listed on the NASDAQ.